EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

Last updated 29 April 2024. Database contains 4821 unique substances/entries.

Filter the list

Showing 101 - 150 of 4,821 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC
trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate	429-240-8	212652-59-0	Eye Dam. 1
trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate	427-710-7	215612-56-9	Eye Dam. 1; Skin Sens. 1
trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex BLUE TZ 4312	423-770-3	-	Eye Dam. 1
trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)-2',2'',4-trisulfonate SCARLET 12 04 262	406-820-9	159317-41-6	Eye Irrit. 2
trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-) SÄUREBLAU 82 226	402-500-8	104105-46-6	Eye Dam. 1
trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II) BROWN 1612969	407-110-1	480445-87-2	Eye Dam. 1; Skin Sens. 1
tris[2-chloro-1-(chloromethyl)ethyl] phosphate	237-159-2	13674-87-8	Carc. 2
tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate LEXMARK YELLOW DYE 415; PRISM YELLOW	406-073-9	131013-81-5	Acute Tox. 3
tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II) PIGMENTBLAU 1755	403-210-4	108300-90-9	Eye Dam. 1
tris(nonylphenyl) phosphite	247-759-6	26523-78-4	Skin Sens. 1	yes
Tris(4-nonylphenyl, branched) phosphite show/hide Phenol, p-isononyl-, phosphite (3:1) EC / List no: - \| CAS no: 31631-13-7 Phenol, 4-nonyl-, phosphite (3:1) EC / List no: 608-492-4 \| CAS no: 3050-88-2 Tris(nonylphenyl) phosphite EC / List no: 247-759-6 \| CAS no: 26523-78-4 tris(4-nonylphenyl, branched) phosphite EC / List no: 701-028-2 \| CAS no: - Phenol, p-sec-nonyl-, phosphite EC / List no: - \| CAS no: 106599-06-8	799-976-5	-		yes
tris(2-methoxyethoxy)vinylsilane; 6-(2-methoxyethoxy)-6-vinyl-2,5,7,10-tetraoxa-6-silaundecane	213-934-0	1067-53-4	Repr. 1B	yes
tris(2-chloroethyl)phosphate	204-118-5	115-96-8	Carc. 2; Repr. 1B; Acute Tox. 4	yes
tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate ACETOACETYLORTHOSINIC ACID, A6-SALT	403-760-5	68030-79-5	Skin Sens. 1
tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate	-	7276-58-6	Acute Tox. 4
tripropyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 3
tripropylammonium dihydrogenphosphate TRYPROPYLAMMONIUM DIHYDROGENPHOSPHAT	433-700-3	35687-90-2	Acute Tox. 4
triphenyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 3
triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)	442-960-7	332350-93-3	Acute Tox. 3; Eye Dam. 1
triphenyl phosphite	202-908-4	101-02-0	Eye Irrit. 2; Skin Irrit. 2
trioctyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
trioctylstannane TZ 02508	413-320-4	869-59-0	STOT RE 1; Skin Irrit. 2
trinickel tetrasulfide	-	12137-12-1	Carc. 1A; STOT RE 1; Skin Sens. 1
trinickel disulfide; nickel subsulfide	234-829-6	12035-72-2	Carc. 1A; Muta. 2; Acute Tox. 3; STOT RE 1; Skin Sens. 1
trinickel boride	234-495-1	12007-02-2	Carc. 1A; STOT RE 1; Skin Sens. 1
trinickel bis(orthophosphate)	233-844-5	10381-36-9	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
trinickel bis(arsenite)	-	74646-29-0	Carc. 1A; STOT RE 1; Skin Sens. 1
trinickel bis(arsenate); nickel(II) arsenate	236-771-7	13477-70-8	Carc. 1A; STOT RE 1; Skin Sens. 1
trinexapac-ethyl (ISO); ethyl 4-[cyclopropyl (hydroxy) methylene]-3,5-dioxocyclohexanecarboxylate	680-302-2	95266-40-3	STOT RE 2; Skin Sens. 1B
trimethyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 2; Acute Tox. 1
trimethylopropane tri(3-aziridinylpropanoate); (TAZ)	257-765-0	52234-82-9	Muta. 2; Eye Dam. 1; Skin Sens. 1
trimethylenediaminetetraacetic acid 1,3-PDTA; AGENT CHELATANT KODAK NO.1; DISSOLVINE PDZ; HAMPSHIRE PDTA; KODAK CHELATING AGENT NO.1; TRILON R FS	400-400-9	1939-36-2	Acute Tox. 4; Eye Dam. 1
trimethyl borate	204-468-9	121-43-7	Flam. Liq. 3; Acute Tox. 4
trimethoxyvinylsilane; trimethoxy(vinyl)silane	220-449-8	2768-02-7	Skin Sens. 1B
trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate IJA-286; IJBK-286; IJBK-286-LI	403-650-7	117409-78-6	Expl. 1.3
trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-) ACID BLUE FC 77890	414-290-5	149564-65-8	Acute Tox. 4
Trilead dioxide phosphonate	235-252-2	12141-20-7		yes
Trilead diarsenate	222-979-5	3687-31-8		yes
trilead bis(orthophosphate)	231-205-5	7446-27-7	Repr. 1A; STOT RE 2
Trilead bis(carbonate)dihydroxide	215-290-6	1319-46-6		yes
trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-)	235-688-3	12519-85-6	Carc. 1A; STOT RE 1; Skin Sens. 1
triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6- (2,2,2-trifluoroethoxy)-1,3,5- triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoate	603-146-9	126535-15-7	Carc. 2
trifluralin (ISO) (containing <0.5 ppm NPDA); α, α, α-trifluoro-2,6-dinitro-N, N-dipropyl-p-toluidine (containing; < 0,5 ppm NPDA); 2,6-dinitro-N, N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA); N, N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA)	216-428-8	1582-09-8	Carc. 2; Skin Sens. 1
trifluoroiodomethane; trifluoromethyl iodide	219-014-5	2314-97-8	Muta. 2
trifluoroacetic acid . . . %	200-929-3	76-05-1	Acute Tox. 4; Skin Corr. 1A
triflumizole (ISO); (1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimine	614-708-8	68694-11-1	Repr. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1
trifloxystrobin (ISO); methyl (E)-methoxyimino-{(E)-α-[1-(α,α,α-trifluoro-m-tolyl) ethylideneaminooxy]-o-tolyl}acetate	604-237-6	141517-21-7	Lact.; Skin Sens. 1
trifenmorph (ISO);4-tritylmorpholine	215-812-2	1420-06-0	Acute Tox. 4
triethyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 2; Acute Tox. 1
triethylamine	204-469-4	121-44-8	Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1A

Showing 101 - 150 of 4,821 results.

Export search results to:

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 29 April 2024. Database contains 4821 unique substances/entries.

Footer Nav Items